about
Clinical perspectives of TRAIL: insights into central nervous system disordersVitamin D Modulation of TRAIL Expression in Human Milk and Mammary Epithelial Cells.miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.H-Ras regulation of TRAIL death receptor mediated apoptosisInterplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayFirst-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer AgentExpression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.Ethanolic extract of Descurainia sophia seeds sensitizes A549 human lung cancer cells to TRAIL cytotoxicity by upregulating death receptors.The mechanism of Jurkat cells apoptosis induced by Aggregatibacter actinomycetemcomitans cytolethal distending toxin.Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membraneTRAIL on trial: preclinical advances in cancer therapyTNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new?MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.Major apoptotic mechanisms and genes involved in apoptosis.Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.A role for TRAIL/TRAIL-R2 in radiation-induced apoptosis and radiation-induced bystander response of human neural stem cellsThe DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy.Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones.Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5.Evaluation of serum trail level and DR4 gene variants as biomarkers for vitiligo patients.Lycopene Protects Keratinocytes Against UVB Radiation-Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway.TRAIL in CD8+ T cells from patients with severe aplastic anemia.Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.Developing TRAIL/TRAIL death receptor-based cancer therapies.
P2860
Q26766570-C46A40FB-9679-4430-9C18-B7BB5FF42891Q33849195-822545EB-99DA-420D-AE4B-E9AF6AAE4CC0Q34104106-B63DF92F-274E-4DD4-B537-BAD25BEE9F2EQ34104161-12C89574-7FAF-47F0-87B2-2735DA7FC4E3Q34615002-0C1E4946-D9B2-455D-9412-2C689E12C1ACQ35595688-9504D20B-874A-4C5C-AB67-FC880F3FDDA8Q35844988-042685C7-3333-4A71-B64D-79A27C16ABCEQ35909089-AAAAFDDB-0B0A-4760-B2E9-E99CFD984373Q35951059-E4910867-C33C-4563-A9C7-C8B5C515700BQ35978089-94A18D8D-D9AF-46DF-B71C-B1A20EDC0ADBQ36293421-981C5868-E331-4BA7-AE59-666902266F38Q36395984-292BE312-D76A-49DA-9FE8-8470E8A3F95DQ36873574-63009962-B577-4206-8900-F6CECEB6F612Q37327815-ADEF7997-2986-407C-B6B1-CA7B376CB439Q37433463-EA4ECAB5-A220-4298-BD69-320BEDAC2832Q38070361-BA36801B-9458-4411-AAB3-6EB8921688A1Q38699411-B47D1B53-BD74-46CD-B13D-E69F72CED36CQ38802454-671D96A9-04C0-41E4-9790-ABDC9EDD72BAQ38809124-90A1FECA-B142-40E0-9ED6-830E145630D0Q39070728-43B1D3B6-FB09-4B16-8300-74F37AE91019Q39072507-A5AA6C25-2799-4F52-B520-A22A959F4CADQ39247899-4D54589F-A91F-400A-846B-1DE8B4C7A950Q40936303-B940FB5E-1F64-454E-852C-C1BB12CB31D1Q41038487-7F186C77-1713-4E82-9C1D-6AE11EB874E5Q42365296-28D25619-D800-4658-A9C2-2D2F952C5EBAQ42709967-30B4B98F-8645-4452-A4AB-839E72BF58E3Q45410310-DAE4BB02-28C7-4E96-AC1D-2E127D472261Q47106685-2467EA1B-D06D-4638-BF01-58809B221B79Q47138270-5C96DD79-D908-496D-924B-AD79262985BCQ47856116-9D849A52-291B-407D-8C02-FCF77F84AF2DQ48323024-FAFC58CE-06B2-4493-B136-015186CA18FCQ50576783-93D5D810-013F-4AA2-BFB2-3ED4E4420108Q53075808-61403FB3-260D-4639-99E1-8B472FB9DD1BQ53701901-3D8B29B0-C0C0-49F5-A40C-1B398825786B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regulation of the human TRAIL gene.
@en
type
label
Regulation of the human TRAIL gene.
@en
prefLabel
Regulation of the human TRAIL gene.
@en
P2860
P921
P356
P1476
Regulation of the human TRAIL gene
@en
P2093
Joshua E Allen
P2860
P304
P356
10.4161/CBT.21354
P577
2012-08-15T00:00:00Z